Last summer’s Impact Report featured the introduction of the Catapult Initiative and highlighted the fantastic work of the six Young Investigator 2 grantees.
In the latest winter Impact Report, we continue to share the latest updates about our research programs and grantees, but we also have big news about one of our Acceleration Initiative grantees.
Some highlights of the report include:
- More updates on the groundbreaking Catapult Initiative and how it will advance new treatments and cures.
- An announcement of the Acceleration Initiative 3 grantee, who will study high-risk pediatric sarcomas.
- The latest on Dr. Mary Beckerle’s Acceleration Initiative I project, which has received enough funding to submit an IND application for FDA approval (thanks to the Nick Currey Fund and other generous donors).
- A spotlight on Young Investigator researcher, Dr. Kara Davis.
We’re excited to show how we’re focusing on patient outcomes and accelerating children’s cancer research. Read the full report here.
Want more stories like this?
Get emails that matter, when it matters.